Biotie Therapies Corp. — Form D
Biotie Therapies Corp. of TURKU, H9, a company, filed a Form D exempt-offering notice with the SEC on 2015-06-02. The offering totals $16.3M, of which $6.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2015-06-02
- Form: D
- Accession: 0000950103-15-004416
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $16.3M
- Amount sold: $6.1M
- Remaining: $10.3M
- Minimum investment: $545K
- Investors: 4
- Date of first sale: 2015-05-28
- Security types: debt
- Revenue range: $5,000,001 - $25,000,000
- SEC file number: 021-240976
Issuer
- Name: Biotie Therapies Corp.
- CIK: 0001579695
- Entity type: Corporation
- Jurisdiction: FINLAND
- Address: JOUKAHAISENKATU 6, TURKU, H9, FI-20520
- Phone: 358-2-274-8900
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Don Matthew Bailey | Director | TURKU, H9 |
| Williams Burns | Director | TURKU, H9 |
| Merja Karhapaa | Director | TURKU, H9 |
| Bernd Kastler | Director | TURKU, H9 |
| ISMAIL KOLA | Director | Cleveland, OH |
| Guido Magni | Director | Watertown, MA |
| Mahendra G Shah | Director | TURKU, H9 |
| Stephen Bandak | Executive Officer | SOUTH SAN FRANCISCO, CA |
| David Cook | Executive Officer | New York, NY |
| Medhi Paborji | Executive Officer | SOUTH SAN FRANCISCO, CA |
| Timo Veromaa | Executive Officer | TURKU, H9 |
| William Burns | Director | McKinney, TX |
| Ian Massey | Executive Officer | NOVATO, CA |
| Peter Fellner | Director | Turku, H9 |
Other filings by this issuer (1)
More